MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,136,000 | +20.6% | 600,000 | 0.0% | 0.47% | +28.4% |
Q2 2023 | $21,678,000 | +57.1% | 600,000 | +61.7% | 0.37% | +44.7% |
Q1 2023 | $13,797,572 | +49.6% | 371,102 | +82.3% | 0.25% | +39.0% |
Q4 2022 | $9,225,116 | -35.1% | 203,600 | 0.0% | 0.18% | -35.0% |
Q3 2022 | $14,219,000 | +87.4% | 203,600 | +80.2% | 0.28% | +72.8% |
Q2 2022 | $7,586,000 | -79.7% | 113,000 | -75.1% | 0.16% | -72.3% |
Q1 2022 | $37,310,000 | -12.8% | 453,781 | +55.6% | 0.58% | +6.9% |
Q4 2021 | $42,779,000 | +86.8% | 291,626 | +125.2% | 0.55% | +81.1% |
Q3 2021 | $22,905,000 | +9.5% | 129,471 | 0.0% | 0.30% | +7.5% |
Q2 2021 | $20,913,000 | -5.7% | 129,471 | 0.0% | 0.28% | -14.6% |
Q1 2021 | $22,178,000 | -22.0% | 129,471 | 0.0% | 0.33% | -24.5% |
Q4 2020 | $28,437,000 | -43.1% | 129,471 | -57.0% | 0.44% | -55.4% |
Q3 2020 | $49,981,000 | +45.4% | 301,000 | 0.0% | 0.98% | +30.9% |
Q2 2020 | $34,365,000 | +48.5% | 301,000 | 0.0% | 0.75% | -0.3% |
Q1 2020 | $23,138,000 | -40.3% | 301,000 | 0.0% | 0.75% | -31.5% |
Q4 2019 | $38,787,000 | +65.4% | 301,000 | 0.0% | 1.09% | +41.0% |
Q3 2019 | $23,451,000 | -6.3% | 301,000 | +23.9% | 0.78% | +1.8% |
Q2 2019 | $25,029,000 | – | 243,000 | – | 0.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |